References
- Center for Disease Control (CDC). Update: acquired immunodeficiency syndrome (AIDS), United States. MMWR 1986; 35: 17–31
- Hughes W T, Riviera G K, Schell M J. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987; 316: 1627–1632
- Fischl M A, Dickinsson G M, La Voie L. Safety and efficacy of sulphamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988; 259: 1185–1189
- Hirschel B, Lazzarin A, Chopard P, Opravil M, Furrer H J, Rüttiman S, Vernazza P, Chave J P, Ancarani F, Gabriel V, Heald A, King R, Malinverni R, Martin J L, Mermillod B, Nocod L, Simoni L, Vivirito M C, Zerboni R, Swiss Group for Clinical Studies. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991; 324: 1079–1083
- Centers for Disease control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989; 38(S-5)6
- Revision of the CDC surveillance case difinition for acquired immunodeficiency syndrome. MMWR 1987; 36(Suppl S1)3S–14S
- Phair J P, Alvaro M, Detels R, Kaslow R, Rinaldo C, Saah A, The Multicenter AIDS Cohort Study Group. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990; 322: 161–165
- Taylor J MG, Fahey J L, Detels R, Giorgio J V. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J Acquir Immune Defic Syndr 1989; 2: 114–124